American Well Corporation
AMWL · Price history
Price at last available close
$13.59
+$0.15 (+1.12%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About American Well Corporation
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services.
How they make money
Amwell operates an enterprise software platform that enables hybrid care delivery for health systems and health plans. The company generates revenue primarily through subscription fees for access to its platform, professional services for implementation and configuration, and fees associated with virtual care visits conducted on its infrastructure.
Products & services
The Amwell Platform is an enterprise software solution that supports hybrid care models, including provider-to-provider virtual care, virtual nursing, e-sitting, and chronic care management, designed to integrate with existing client healthcare investments.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company discloses that it has significant customer concentration, where a limited number of health plans and health systems account for a substantial portion of its total revenue as of December 31, 2025.
Suppliers, materials & equipment
- Cloud infrastructure providers — The company relies on third-party cloud computing services to host its platform and store data.Source
Strengths
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
28
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
26
Poor
Financial Strength
55
Business Quality / Moat
0
Management
40
Growth Quality
0
Risk / Durability
11
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
22
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
28/100
Building Historical Record
Model Score 28/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for AMWL
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving AMWL's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can AMWL fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •How is AMWL likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What specifically needs to improve for AMWL to reach sustainable profitability?
- •What future growth or profitability would be needed to justify AMWL's current valuation?
Essential Investment Snapshot
Wall Street Score
28
Opportunity Score
22
Market Cap
$231.1M
P/E Ratio
-2.8
EPS
$-4.77
52-Week High
$14.19
52-Week Low
$3.71
Beta
1.71
Analyst Target
$12.50
Shares Outstanding
16.0M
Total Revenue
$218.5M
Total Debt
$3.0M
Dividend
No current dividend
Liquidation Value / Share
$14.60
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for AMWL
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on AMWL.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Large installed base of health plans and health systems.
- +Scalable and configurable hybrid care platform.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Information Services industry.
- −Dependence on a limited number of customers for a significant portion of revenue.
- −Risks associated with the migration of clients to the Amwell Platform.
- −Negative free cash flow may increase the need for outside financing and dilution.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
28
Sep 8, 2026
Change
-0.1
points
Current Score
28
Oct 1, 2026
Category Changes
AMWL decreased 0.1 points because some fundamentals weakened.
Projected Score
Projected Score
27
Projected Change
-1.1 points
Preliminary comparable-period financial changes suggest decline of approximately 1.1 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$13.59
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $218.5M | $249.3M | $254.4M | $259.0M | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $112.7M | $116.5M | $155.4M | $164.3M | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $105.8M | $132.9M | $99.0M | $94.8M | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $55.3M | $72.9M | $86.1M | $105.8M | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $107.1M | $131.3M | $197.4M | $213.1M | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $182.8M | $238.1M | $316.5M | $786.9M | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$44.1M | -$60.6M | -$176.9M | -$224.2M | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$77.0M | -$105.3M | -$217.5M | -$692.1M | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $617K | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$76.7M | -$94.5M | -$209.9M | -$675.3M | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $260K | $434K | $2.8M | $3.9M | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$78.1M | -$95.7M | -$208.1M | -$675.2M | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-4.77 | $-5.96 | $-13.88 | $-47.50 | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 16.76M | 16.05M | 15.00M | 14.21M | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 16.76M | 16.05M | 15.00M | 14.21M | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$52.0M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.59
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-53.4%
Cash Change
-10.6%
Margin Change
+8.7 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included debt levels, net income margin. Pressure indicators included revenue growth, EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 26.6%. EPS declined 52.4%. Cash declined 10.6%. Total debt declined 53.4%. Net income margin improved by 8.7 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare Information ServicesNews
Amwell® to report third quarter 2026 operating results
Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
A Look at American Well Corp (AMWL) After 3.4% Gain -- GF Value $6.30 vs Price $13.58
Rumor Mill · AMWL
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial